Home›Retrovir›Retrovir + Lovotibeglogene Autotemcel

Does Retrovir Interact with Lovotibeglogene Autotemcel?

Retrovir and Lovotibeglogene Autotemcel have a major drug interaction according to U.S. FDA drug labeling data. Anti-retroviral medications may interfere with manufacturing of LYFGENIA. Discontinue at least one month prior to mobilization and until all cycles of apheresis are completed. Some long-acting anti-retrovirals may require longer discontinuation. The mechanism involves may interfere with manufacturing of lyfgenia. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Major
Management
Close medical supervision required
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Retrovir and Lovotibeglogene Autotemcel occurs because may interfere with manufacturing of lyfgenia. Clinically, this means anti-retroviral medications may interfere with manufacturing of lyfgenia. discontinue at least one month prior to mobilization and until all cycles of apheresis are completed. some long-acting anti-retrovirals may require longer discontinuation. This is classified as a major interaction, meaning it could cause serious harm if not properly managed. Your healthcare provider may need to adjust dosages, substitute one medication, or increase monitoring frequency.

What To Tell Your Doctor or Pharmacist

If you are taking Retrovir and your doctor is considering prescribing Lovotibeglogene Autotemcel (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask how frequently you should be monitored while these are co-prescribed
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Retrovir+💊 Lovotibeglogene Autotemcel(Lyfgenia)

Severity & Interaction Details

⚠️
major
Use with caution — major interaction
Serious risk of clinically significant harm. Generally avoid; if used, monitor closely.
Severity scale
MinorContra
On record
Yes
Drug A class
—
Drug B class
—
Source
NLP:lovotibeglogene autotemcel

What this means in plain English

Anti-retroviral medications may interfere with manufacturing of LYFGENIA. Discontinue at least one month prior to mobilization and until all cycles of apheresis are completed. Some long-acting anti-retrovirals may require longer discontinuation.

What the FDA label says

"May interfere with manufacturing of LYFGENIA"

📖 Source: NLP:lovotibeglogene autotemcel

Share this result:XFacebookWhatsAppReddit
Add more drugs
Check Retrovir and Lovotibeglogene Autotemcel against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.